StockData
AKANNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

AKANDA CORP.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 9, 2026
$1.12−0.08 (-6.67%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Margins

Share of revenue, fiscal years 2018 to 2025

Gross margin

-60.5%+2760.9 pts over 5 years

Operating margin

-1931.0%+78850.0 pts over 5 years